Ready for 2025? How Lessons Learned From National System Reforms Can Guide Our Response to the New EU HTA Regulations

Author(s)

Moderator: Herbert Altmann, PhD, Cencora, England, UK
Panelists: Iga Lipska, MD, PhD, MPH, Health Policy Institute, Medical University of Gdańsk, Gdańsk, Poland; François Meyer, MD, FIPRA Public Affairs, Paris, France; Oriol Solà-Morales, MD, PhD, Health Innovation Technology Transfer, Barcelona, B, Spain; Mihai Rotaru, MSc, European Federation of Pharmaceutical Industries and Associations, Brussels, Belgium; Max Brosa, MBA, Self-Employed, Sant Vicenç de Montalt, B, Spain

Presentation Documents

Anticipating the imminent launch of the joint clinical assessment (JCA) in January 2025, the healthcare industry in Europe is bracing for a transformative shift in how innovations are evaluated and approved.

In light of the recent reforms in key European countries such as Germany, Spain, France and Poland, our panel of experts will delve into the evolving landscape.

Join us as we unravel the essential healthcare system requirements and policies crucial for accelerating patient access to groundbreaking medicines.

What attendees will come away with:

  • Fresh insights into how Germany, Spain, France and Poland have reformed their HTA processes and the impact of these reforms on healthcare access, innovation, and pricing
  • Strategies to align national systems with EU regulations to ensure smooth implementation
  • Insights on how national reforms can act as a blueprint for adapting to these evolving challenges and leveraging opportunities for improving patient outcomes

Sponsor: Cencora

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Code

138

Topic

Health Technology Assessment

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×